MUSCAT: Oman has agreed to fast-track the approval of Indian pharma products registered by regulatory agencies in the US, the UK and the EU, the commerce and industry ministry said after the 10th India-Oman Joint Commission Meeting on Wednesday.
“Fast-tracking of approvals for registration of Indian pharmaceutical products already registered by US Food and Drug Administration (US FDA), UK’s Medicines and Healthcare products Regulatory Agency (UKMHRA) and European Medicines Agency (EMA) was agreed to during the deliberations,” a statement released by the ministry said.
“Both sides expressed commitment to facilitate trade and to comprehensively address all issues pertaining to Tariff ot Non-Tariff Barriers.
“Agreement on expeditious conclusion of all Memorandum of Understanding (MoUs) or Agreements under discussion, including on standards and metrology, India-Oman Double Taxation Avoidance Agreement, India-Oman Bilateral Investment Treaty, Invest Oman and Invest India, and Rupay card acceptance in Oman,” the ministry added.
Read More
- Qatar FM arrives in Oman for official visit
- His Majesty issues Royal Decree amending penal code, repeals labour law provision
- CPA seizes over 400 unsafe children’s products in Muscat
- Oman, Iran form working group on future Strait of Hormuz navigation
- Tourism and hotel establishments in Oman asked to regularise status under new regulations
His Excellency Qais Al Yousef, Minister of Commerce, Industry and Investment Promotion is currently visiting India as part of the 10th India-Oman Joint Committee Meet.
